These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Metallothionein (MT) -I and MT-II expression are induced and cause zinc sequestration in the liver after brain injury. Pankhurst MW; Gell DA; Butler CW; Kirkcaldie MT; West AK; Chung RS PLoS One; 2012; 7(2):e31185. PubMed ID: 22363575 [TBL] [Abstract][Full Text] [Related]
67. Potential roles of metallothioneins I and II in protecting bone growth following acute methotrexate chemotherapy. Fan C; Garcia M; Scherer M; Tran C; Xian CJ J Chemother; 2014 Feb; 26(1):37-48. PubMed ID: 24090452 [TBL] [Abstract][Full Text] [Related]
68. Deleterious effects of minocycline after in vivo target deprivation of thalamocortical neurons in the immature, metallothionein-deficient mouse brain. Potter EG; Cheng Y; Natale JE J Neurosci Res; 2009 May; 87(6):1356-68. PubMed ID: 19115404 [TBL] [Abstract][Full Text] [Related]
69. Distribution of exogenous metallothionein following intraperitoneal and intramuscular injection of metallothionein-deficient mice. Lewis KE; Chung RS; West AK; Chuah MI Histol Histopathol; 2012 Nov; 27(11):1459-70. PubMed ID: 23018245 [TBL] [Abstract][Full Text] [Related]
70. Protective role of metallothioneins in the injured mammalian brain. West AK; Chuah MI; Vickers JC; Chung RS Rev Neurosci; 2004; 15(3):157-66. PubMed ID: 15357139 [TBL] [Abstract][Full Text] [Related]
71. Evidence for a protective role of metallothionein-1 in focal cerebral ischemia. van Lookeren Campagne M; Thibodeaux H; van Bruggen N; Cairns B; Gerlai R; Palmer JT; Williams SP; Lowe DG Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12870-5. PubMed ID: 10536015 [TBL] [Abstract][Full Text] [Related]
72. Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease. Ebadi M; Sharma S Exp Biol Med (Maywood); 2006 Oct; 231(9):1576-83. PubMed ID: 17018883 [TBL] [Abstract][Full Text] [Related]
73. CNS wound healing is severely depressed in metallothionein I- and II-deficient mice. Penkowa M; Carrasco J; Giralt M; Moos T; Hidalgo J J Neurosci; 1999 Apr; 19(7):2535-45. PubMed ID: 10087067 [TBL] [Abstract][Full Text] [Related]
74. In cortical cultures of trisomy 16 mouse brain the upregulated metallothionein-I/II fails to respond to H2O2 exposure or glutamate receptor stimulation. Scortegagna M; Galdzicki Z; Rapoport SI; Hanbauer I Brain Res; 1998 Mar; 787(2):292-8. PubMed ID: 9518655 [TBL] [Abstract][Full Text] [Related]
76. Neuroprotective and neuroregenerative properties of metallothioneins. Santos CR; Martinho A; Quintela T; Gonçalves I IUBMB Life; 2012 Feb; 64(2):126-35. PubMed ID: 22131188 [TBL] [Abstract][Full Text] [Related]
77. Metallothioneins are neuroprotective agents in lysosomal storage disorders. Cavalca E; Cesani M; Gifford JC; Sena-Esteves M; Terreni MR; Leoncini G; Peviani M; Biffi A Ann Neurol; 2018 Feb; 83(2):418-432. PubMed ID: 29369397 [TBL] [Abstract][Full Text] [Related]
78. Sildenafil-Mediated Neuroprotection from Adult to Neonatal Brain Injury: Evidence, Mechanisms, and Future Translation. Zinni M; Pansiot J; Léger PL; El Kamouh M; Baud O Cells; 2021 Oct; 10(10):. PubMed ID: 34685745 [TBL] [Abstract][Full Text] [Related]
79. The Balance between Life and Death of Cells: Roles of Metallothioneins. Nielsen AE; Bohr A; Penkowa M Biomark Insights; 2007 Feb; 1():99-111. PubMed ID: 19690641 [TBL] [Abstract][Full Text] [Related]
80. Metallothioneins and brain injury: What transgenic mice tell us. Hidalgo J Environ Health Prev Med; 2004 May; 9(3):87-94. PubMed ID: 21432316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]